Characteristics of Relapse Affect Treatment Choices in Multi

Natalie S. Callander, MD, director of the University of Wisconsin Carbone Cancer Center Myeloma Clinical Program, reviewed the treatment landscape at the National Comprehensive Cancer Network (NCCN) 2023 Annual Conference.

Related Keywords

United States , Wisconsin , American , Natalies Callander , , National Comprehensive Cancer Network , National Cancer Institute , Glaxosmithkline , American Society Of Hematology , American Society , Multiple Myeloma , Clinical Guidelines , Cart Cell Therapy , Monoclonal Antibodies , Bispecific , Nccn ,